|
1
|
Ishida T and Sakaguchi I: Protection of
human keratinocytes from UVB-induced inflammation using root
extract of Lithospermum erythrorhizon. Biol Pharm Bull. 30:928–934.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Yeh CC, Kuo HM, Li TM, et al:
Shikonin-induced apoptosis involves caspase-3 activity in a human
bladder cancer cell line (T24). In Vivo. 21:1011–1019. 2007.
|
|
3
|
Wu Z, Wu LJ, Tashiro S, et al:
Phosphorylated extracellular signal-regulated kinase up-regulated
p53 expression in shikonin-induced HeLa cell apoptosis. Chin Med J
(Engl). 118:671–677. 2005.
|
|
4
|
Li W, Liu J, Jackson K, Shi R and Zhao Y:
Sensitizing the therapeutic efficacy of taxol with shikonin in
human breast cancer cells. PloS One. 9:e940792014. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Jang SY, Jang EH, Jeong SY and Kim JH:
Shikonin inhibits the growth of human prostate cancer cells via
modulation of the androgen receptor. Int J Oncol. 44:1455–1460.
2014.PubMed/NCBI
|
|
6
|
Wang W, Dai M, Zhu C, et al: Synthesis and
biological activity of novel shikonin analogues. Bioorg Med Chem
Lett. 19:735–737. 2009. View Article : Google Scholar
|
|
7
|
Al-Obeidi FA and Lam KS: Development of
inhibitors for protein tyrosine kinases. Oncogene. 19:5690–5701.
2000. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Hunter T: Protein kinases and
phosphatases: the yin and yang of protein phosphorylation and
signaling. Cell. 80:225–236. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Wheeler DL, Iida M and Dunn EF: The role
of Src in solid tumors. Oncologist. 14:667–678. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Wiener JR, Windham TC, Estrella VC, et al:
Activated SRC protein tyrosine kinase is overexpressed in
late-stage human ovarian cancers. Gynecol Oncol. 88:73–79. 2003.
View Article : Google Scholar
|
|
11
|
Parsons JT: Focal adhesion kinase: the
first ten years. J Cell Sci. 116:1409–1416. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Westhoff MA, Serrels B, Fincham VJ, et al:
SRC-mediated phosphorylation of focal adhesion kinase couples actin
and adhesion dynamics to survival signaling. Mol Cell Biol.
24:8113–8133. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Schlaepfer DD and Mitra SK: Multiple
connections link FAK to cell motility and invasion. Curr Opin Genet
Dev. 14:92–101. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Peng X, Ueda H, Zhou H, et al:
Overexpression of focal adhesion kinase in vascular endothelial
cells promotes angiogenesis in transgenic mice. Cardiovasc Res.
64:421–430. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Judson PL, He X, Cance WG and Van Le L:
Overexpression of focal adhesion kinase, a protein tyrosine kinase,
in ovarian carcinoma. Cancer. 86:1551–1556. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Sankawa U, Ebizuka Y, Miyazaki T, Isomura
Y and Otsuka H: Antitumor activity of shikonin and its derivatives.
Chem Pharm Bull (Tokyo). 25:2392–2395. 1977. View Article : Google Scholar
|
|
17
|
Sankawa U, Otsuka H, Kataoka Y, Iitaka Y,
Hoshi A and Kuretani K: Antitumor activity of shikonin, alkannin
and their derivatives. II X-ray analysis of cyclo-alkannin
leucoacetate, tautomerism of alkannin and cyclo-alkannin and
antitumor activity of alkannin derivatives. Chem Pharm Bull
(Tokyo). 29:116–122. 1981. View Article : Google Scholar
|
|
18
|
Yang H, Zhou P, Huang H, et al: Shikonin
exerts antitumor activity via proteasome inhibition and cell death
induction in vitro and in vivo. Int J Cancer. 124:2450–2459. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Lee HJ, Lee HJ, Magesh V, Nam D, et al:
Shikonin, acetylshikonin and isobutyroylshikonin inhibit
VEGF-induced angiogenesis and suppress tumor growth in lewis lung
carcinoma-bearing mice. Yakugaku Zasshi. 128:1681–1688. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Wu Z, Wu L, Li L, Tashiro S, Onodera S and
Ikejima T: p53-mediated cell cycle arrest and apoptosis induced by
shikonin via a caspase-9-dependent mechanism in human malignant
melanoma A375-S2 cells. J Pharmacol Sci. 94:166–176. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Han W, Li L, Qiu S, et al: Shikonin
circumvents cancer drug resistance by induction of a necroptotic
death. Mol Cancer Ther. 6:1641–1649. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Hsu PC, Huang YT, Tsai ML, Wang YJ, Lin JK
and Pan MH: Induction of apoptosis by shikonin through coordinative
modulation of the Bcl-2 family, p27 and p53, release of cytochrome
c and sequential activation of caspases in human colorectal
carcinoma cells. J Agric Food Chem. 52:6330–6337. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Wu Z, Wu LJ, Li LH, Tashiro S, Onodera S
and Ikejima T: Shikonin regulates HeLa cell death via caspase-3
activation and blockage of DNA synthesis. J Asian Nat Prod Res.
6:155–166. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Nakaya K and Miyasaka T: A shikonin
derivative, beta-hydroxyisovalerylshikonin, is an
ATP-non-competitive inhibitor of protein tyrosine kinases.
Anticancer Drugs. 14:683–693. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Roskoski R Jr: Src kinase regulation by
phosphorylation and dephosphorylation. Biochem Biophys Res Commun.
331:1–14. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Schlaepfer DD and Hunter T: Integrin
signalling and tyrosine phosphorylation: just the FAKs? Trends Cell
Biol. 8:151–157. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Hanks SK, Calalb MB, Harper MC and Patel
SK: Focal adhesion protein-tyrosine kinase phosphorylated in
response to cell attachment to fibronectin. Proc Natl Acad Sci USA.
89:8487–8491. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Schaller MD, Borgman CA, Cobb BS, Vines
RR, Reynolds AB and Parsons JT: pp125FAK a structurally distinctive
protein-tyrosine kinase associated with focal adhesions. Proc Natl
Acad Sci USA. 89:5192–5196. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Calalb MB, Polte TR and Hanks SK: Tyrosine
phosphorylation of focal adhesion kinase at sites in the catalytic
domain regulates kinase activity: a role for Src family kinases.
Mol Cell Biol. 15:954–963. 1995.PubMed/NCBI
|
|
30
|
Cobb BS, Schaller MD, Leu TH and Parsons
JT: Stable association of pp60src and pp59fyn with the focal
adhesion-associated protein tyrosine kinase, pp125FAK. Mol Cell
Biol. 14:147–155. 1994.PubMed/NCBI
|
|
31
|
Baron V, Calléja V, Ferrari P, Alengrin F
and Van Obberghen E: p125Fak focal adhesion kinase is a substrate
for the insulin and insulin-like growth factor-I tyrosine kinase
receptors. J Biol Chem. 273:7162–7168. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Schlaepfer DD, Hanks SK, Hunter T and van
der Geer P: Integrin-mediated signal transduction linked to Ras
pathway by GRB2 binding to focal adhesion kinase. Nature.
372:786–791. 1994. View
Article : Google Scholar : PubMed/NCBI
|
|
33
|
Recher C, Ysebaert L, Beyne-Rauzy O, et
al: Expression of focal adhesion kinase in acute myeloid leukemia
is associated with enhanced blast migration, increased cellularity
and poor prognosis. Cancer Res. 64:3191–3197. 2004. View Article : Google Scholar : PubMed/NCBI
|
